Skip to main content

Atrial Fibrillation: Assessment of Thromboembolic Risk Factors (CHADS2)

CBE ID
1524
1.4 Project
Cardiovascular
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2014
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 18 years and older with a diagnosis of nonvalvular atrial fibrillation (AF) or atrial flutter in whom assessment of all the specified thromboembolic risk factors using the CHADS2 risk criteria is documented

    • 1.14 Numerator

      Patients in whom assessment of all of the specified thromboembolic risk factors using the CHADS2 risk criteria is documented

    • 1.15 Denominator

      All patients aged 18 years and older with a diagnosis of nonvalvular atrial fibrillation (AF) or atrial flutter

    • Exclusions

      Denominator exclusions include patients with mitral stenosis or prosthetic heart valves, patients with transient or reversible cause of AF (eg, pneumonia, hyperthyroidism, pregnancy, cardiac surgery).

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cardiovascular Project 2014-2015
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      American College of Cardiology
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      This Physician Performance Measurement Set (PPMS) and related data specifications were developed by the American Medical Association (AMA)-convened Physician Consortium for Performance Improvement® (PCPI®) including the American College of Cardiology (ACC) and the American Heart Association (AHA) to facilitate quality improvement activities by physicians. The performance measures contained in this PPMS are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.
      While copyrighted, they can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the performance measures for commercial gain, or incorporation of the performance measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the performance measures require a license agreement between the user and the AMA, (on behalf of the PCPI) or the ACC or the AHA. Neither the ACC, AHA, PCPI nor its members shall be responsible for any use of this PPMS.
      THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.
      © 2007, 2013 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.
      Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, the ACC, the AHA, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.
      CPT® contained in the measures specifications is copyright 2004-2012 American Medical Association. LOINC® copyright 2004-2012 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms® (SNOMED CT®) copyright 2004-2012 International Health Terminology Standards Development Organisation. ICD-10 Copyright 2012 World Health Organization. All Rights Reserved.